Ablative radiation therapy to restrain everything safely treatable (ARREST): study protocol for a phase I trial treating polymetastatic cancer with stereotactic radiotherapy by Glenn S. Bauman, Mark T. Corkum, Hatim Fakir, Timothy K. Nguyen, David A. Palma

Get full text

Dosimetric Evaluation of PSMA PET-Delineated Dominant Intraprostatic Lesion Simultaneous Infield Boosts by Christopher D. Goodman, MD, Hatim Fakir, PhD, Stephen Pautler, MD, Joseph Chin, MD, Glenn S. Bauman, MD

Get full text

Can Polymetastatic Disease Be ARRESTed Using SABR? A Dosimetric Feasibility Study to Inform Development of a Phase 1 Trial by Mark T. Corkum, MD, MSc, Hatim Fakir, PhD, David A. Palma, MD, PhD, Timothy Nguyen, MD, Glenn S. Bauman, MD

Get full text

Imaging Biomarkers in Prostate Stereotactic Body Radiotherapy: A Review and Clinical Trial Protocol by Wei Liu, Andrew Loblaw, David Laidley, Hatim Fakir, Lucas Mendez, Melanie Davidson, Zahra Kassam, Ting-Yim Lee, Aaron Ward, Jonathan Thiessen, Jane Bayani, John Conyngham, Laura Bailey, Joseph D. Andrews, Glenn Bauman

Get full text

Defining radio-recurrent intra-prostatic target volumes using PSMA-targeted PET/CT and multi-parametric MRI by Wei Liu, Hatim Fakir, Gurpreet Randhawa, Ryan Alfano, Mark Corkum, Zahra Kassam, Irina Rachinsky, Hans T. Chung, Peter Chung, Andrew Loblaw, Gerard Morton, Tracy Sexton, Anil Kapoor, Aaron Ward, Katherine Zukotynski, Louise Emmett, Glenn Bauman

Get full text

Planning for the Effect of the SC.24 Trial on Spine Stereotactic Body Radiation Therapy Utilization at a Tertiary Cancer Center by Andrew J. Arifin, MD, Sympascho Young, MD, Glenn S. Bauman, MD, Hatim Fakir, PhD, Belal Ahmad, MD, Joanna M. Laba, MD, George B. Rodrigues, MD, PhD, Eric K. Nguyen, MD, Arjun Sahgal, MD, Timothy K. Nguyen, MD, FRCPC

Get full text